We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+11.56%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$8.44B
AUM Growth
+$1.09B
(+15%)
Cap. Flow
+$577M
Cap. Flow
% of AUM
6.84%
Top 10 Holdings %
Top 10 Hldgs %
15.63%
Holding
838
New
218
Increased
181
Reduced
162
Closed
220
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$123M |
| 2 |
HES
Hess
HES
|
+$115M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$108M |
| 4 |
Cencora
COR
|
+$106M |
| 5 |
Microsoft
MSFT
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$108M |
| 2 |
Analog Devices
ADI
|
+$105M |
| 3 |
Keysight
KEYS
|
+$101M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$82.2M |
| 5 |
Booking.com
BKNG
|
+$58.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.55% |
| 2 | Technology | 28% |
| 3 | Industrials | 9.43% |
| 4 | Energy | 7.74% |
| 5 | Consumer Discretionary | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PXD
101
DELISTED
Pioneer Natural Resource Co.
PXD
| $24.7M | 0.29% |
+119,049
| New | +$25.1M |
|
102
On Holding
ONON
$12.1B
| $24.1M | 0.29% |
731,138
-116,486
| -14% | -$3.54M |
|
|
KDNY
103
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $23.7M | 0.28% |
+617,907
| New | +$15.9M |
|
|
EXAS
104
DELISTED
Exact Sciences
EXAS
| $23.6M | 0.28% |
250,863
-44,460
| -15% | -$3.47M |
|
105
United Therapeutics
UTHR
$25.8B
| $23.4M | 0.28% |
106,171
+39,348
| +59% | +$8.72M |
|
106
Avnet
AVT
$7.29B
| $23.1M | 0.27% |
+458,825
| New | +$20.2M |
|
|
DVAX
107
DELISTED
Dynavax Technologies
DVAX
| $23M | 0.27% |
1,782,398
+1,716,617
| +2,610% | +$19.6M |
|
108
Xylem
XYL
$27.3B
| $22.9M | 0.27% |
203,040
+172,259
| +560% | +$18.2M |
|
109
Option Care Health
OPCH
$3.45B
| $22.9M | 0.27% |
703,780
+64,537
| +10% | +$1.95M |
|
110
Editas Medicine
EDIT
$396M
| $22.6M | 0.27% |
2,749,305
+102,685
| +4% | +$895K |
|
111
News Corp Class A
NWSA
$14.9B
| $22.5M | 0.27% |
1,155,435
-377,393
| -25% | -$6.84M |
|
112
Boeing
BA
$171B
| $22.2M | 0.26% |
105,290
-35,000
| -25% | -$7.27M |
|
|
SLRN
113
DELISTED
ACELYRIN
SLRN
| $21.6M | 0.26% |
+1,035,555
| New | +$21.2M |
|
114
AnaptysBio
ANAB
$1.58B
| $21M | 0.25% |
1,034,549
+574,987
| +125% | +$11.7M |
|
115
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.42B
| $20.9M | 0.25% |
+455,573
| New | +$20.8M |
|
|
RETA
116
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $20.9M | 0.25% |
+205,108
| New | +$19.4M |
|
|
OLK
117
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $20.8M | 0.25% |
1,109,607
+160,960
| +17% | +$3.33M |
|
118
Church & Dwight Co
CHD
$23.4B
| $20.6M | 0.24% |
+205,975
| New | +$19.4M |
|
119
VeriSign
VRSN
$26.2B
| $20.6M | 0.24% |
91,020
+45,094
| +98% | +$9.94M |
|
120
Playtika
PLTK
$1.52B
| $20.5M | 0.24% |
1,768,942
+1,215,892
| +220% | +$13.2M |
|
121
Intuitive Surgical
ISRG
$127B
| $20.5M | 0.24% |
60,000
| – | – |
|
122
Antero Resources
AR
$11.1B
| $20.5M | 0.24% |
+888,714
| New | +$19.7M |
|
123
BioMarin Pharmaceuticals
BMRN
$11.6B
| $20.3M | 0.24% |
234,736
+150,013
| +177% | +$14.1M |
|
124
Teledyne Technologies
TDY
$30.4B
| $20.2M | 0.24% |
+49,093
| New | +$20.2M |
|
125
PTC
PTC
$15.8B
| $20M | 0.24% |
+140,263
| New | +$18.6M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Woodline Partners held 838 positions worth $8.44B, up 15% from $7.35B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $577M of net new capital in Q2 2023, opening 218 new positions and adding to 181 existing holdings. Its largest new stake was Hess: 837,083 shares worth $114M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Keysight, an estimated $101M trimmed.
- Woodline Partners's largest Q2 2023 buy was Hess: 837,083 shares worth $114M.
- Woodline Partners added most to Johnson & Johnson in Q2 2023, an estimated $123M increase.
- Woodline Partners's biggest Q2 2023 reduction was Keysight, cutting an estimated $101M.
- Woodline Partners fully exited Baxter International in Q2 2023, selling an estimated $108M.
- Woodline Partners's ten largest holdings make up 16% of its $8.44B portfolio in Q2 2023.
- Woodline Partners opened 218 new positions and closed 220 in Q2 2023.
- Woodline Partners's portfolio value rose 15% quarter-over-quarter to $8.44B.
Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.